© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Medications sometimes prescribed to help manage high cholesterol levels also show promise as add-on treatments for hepatitis C, according to s...
Merck’s HCV protease inhibitor boceprevir can be used safely and effective in people living with hepatitis C virus (HCV) with advanced...
A combination of two experimental once-a-day drugs active against the hepatitis C virus (HCV) is showing excellent potential, without the addi...
An experimental version of pegylated interferon, Peg-Interferon lambda, combined with ribavirin (RBV) appears to be more effective with...
In what is being heralded as a hepatitis C virus (HCV) treatment research breakthrough, a clinical trial evaluating two oral medications being...
Alisporivir, a once-daily drug at the forefront of a new class of hepatitis C virus (HCV) compounds known as cyclophilin inhibitors, significa...
BI 201335 is one of several protease inhibitors being developed to treat HCV.
The only study completed to evaluate treatment on all major subgroups of people with genotype 1 HCV whose earlier treatment was unsuccessful
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.